Human Activin A Receptor Type 1B (ACVR1B) Protein

REQUEST MORE INFO
Catalogue No: abx065136
Price: US$246.50
(Size: 10 µg)

Click on the image to see the image legend

Available Options

* Size:







Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Recombinant Activin A Receptor Type I B (ACVR1B) is a recombinant Human protein produced in a Prokaryotic expression system (E. coli).

Target Activin A Receptor Type 1B (ACVR1B)
Origin Human
Expression Recombinant
Tested Applications WB, SDS-PAGE
Host E. coli
Conjugation Unconjugated
Form Lyophilized
Purity > 90%
Reconstitution To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Storage Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.
UniProt Primary AC P36896 (UniProt, ExPASy)
UniProt Secondary AC B7Z5L8, B7Z5W5, Q15479, Q15480, Q15481, Q15482
UniProt Entry Name ACV1B_HUMAN
KEGG hsa:91
String 9606.ENSP00000442656
Molecular Weight Calculated MW: 12.7 kDa
Observed MW (SDS-PAGE): 13 kDa
Sequence Fragment Ser24-Glu126
Sequence SGPRGVQ ALLCACTSCL QANYTCETDG ACMVSIFNLD GMEHHVRTCI PKVELVPAGK PFYCLSSEDL RNTHCCYTDY CNRIDLRVPS GHLKEPEHPS MWGPVE
Tag N-terminal His tag
Buffer Prior to lyophilization: PBS, pH 7.4, containing 0.01% Sarcosyl, 1 mM DTT, 5% Trehalose and Proclin-300.
Activity Not tested
Concentration Prior to lyophilization: 200 µg/ml
Availability Shipped within 5-7 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on Activin A Receptor Type 1B (ACVR1B)


Write a review